Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Renault stock logo
RNLSY
Renault
$8.85
-1.7%
$10.34
$7.82
$11.20
$14.53B1.3816,133 shs102,940 shs
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$8.52
-1.4%
$8.19
$6.22
$8.97
$14.50B0.1862,144 shs55,634 shs
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
$14.79
$14.79
$10.86
$14.79
$3.68B0.6216,957 shsN/A
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
$23.52
0.0%
$23.65
$21.40
$27.21
$14.67B0.4637,836 shs27,236 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Renault stock logo
RNLSY
Renault
-1.67%-12.55%-19.18%-17.13%-15.55%
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
-1.35%+0.83%+11.96%+11.08%-12.44%
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
0.00%0.00%0.00%0.00%0.00%
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
-0.02%-0.59%-0.72%-4.70%+3.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Renault SA stock logo
RNLSY
Renault
N/AN/AN/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
0.865 of 5 stars
0.03.00.80.01.90.01.3
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
Wilmar International Limited stock logo
WLMIY
Wilmar International
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Renault stock logo
RNLSY
Renault
2.00
HoldN/AN/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
0.00
N/AN/AN/A
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
0.00
N/AN/AN/A
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest UDHCF, WLMIY, SGIOY, and RNLSY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2025
Renault stock logo
RNLSY
Renault
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 6/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Renault stock logo
RNLSY
Renault
$60.85B0.22$4.06 per share2.18$22.76 per share0.39
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$2.88B5.04$0.74 per share11.57$5.29 per share1.61
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
$1.28B2.87$0.74 per share19.91$3.95 per share3.74
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
$67.38B0.22$3.88 per share6.06$35.87 per share0.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Renault stock logo
RNLSY
Renault
$150.41MN/A0.003.13N/AN/AN/AN/A7/31/2025 (Estimated)
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$1.12BN/A14.7213.111.98N/AN/AN/A7/28/2025 (Estimated)
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
$92.83MN/A0.00N/AN/AN/AN/AN/A
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
$1.17BN/A0.00N/AN/AN/AN/A8/11/2025 (Estimated)

Latest UDHCF, WLMIY, SGIOY, and RNLSY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q4 2025
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$0.1654$0.14-$0.0254$0.14$824.23 million$721.77 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Renault stock logo
RNLSY
Renault
$0.303.39%N/AN/AN/A
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
$0.050.59%N/AN/AN/A
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
$0.191.28%N/AN/AN/A
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
$1.395.91%N/AN/AN/A

Latest UDHCF, WLMIY, SGIOY, and RNLSY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2025
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
$0.67024.57%4/30/20255/1/20255/30/2025
5/1/2025
Renault stock logo
RNLSY
Renault
$0.33093.11%5/7/20255/8/20255/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Renault SA stock logo
RNLSY
Renault
N/A
1.03
0.97
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
0.01
7.64
7.01
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
0.35
1.90
1.81
Wilmar International Limited stock logo
WLMIY
Wilmar International
0.33
1.17
0.75
CompanyEmployeesShares OutstandingFree FloatOptionable
Renault stock logo
RNLSY
Renault
98,0001.48 billionN/ANot Optionable
Shionogi & Co., Ltd. Unsponsored ADR stock logo
SGIOY
Shionogi & Co., Ltd. Unsponsored ADR
4,9591.70 billionN/ANot Optionable
UDG Healthcare plc stock logo
UDHCF
UDG Healthcare
9,000248.71 millionN/ANot Optionable
Wilmar International Ltd. stock logo
WLMIY
Wilmar International
100,000624.27 millionN/ANot Optionable

Recent News About These Companies

Analysts wary of Wilmar’s outlook amid tariff impact

New MarketBeat Followers Over Time

Media Sentiment Over Time

Renault stock logo

Renault OTCMKTS:RNLSY

$8.85 -0.15 (-1.67%)
As of 06/17/2025 03:58 PM Eastern

Renault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. It also engages in the design and production of parts and equipment used for manufacturing and operation vehicles. The company operates through Automotive, Sale Financing, and Mobility Services segments. Its Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in Nissan. The company's Sale Financing segment offers sale financing, leasing, maintenance, and services contract under the Mobilize Financial Services brand. Its Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize brand. In addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles under the Renault, Dacia, Alpine, and Mobilize brands. Further, the company offers used vehicles and spare parts; and engages in business-to-business powertrain activities, and research and advanced engineering activities. Renault SA was founded in 1898 and is based in Boulogne-Billancourt, France.

Shionogi & Co., Ltd. Unsponsored ADR stock logo

Shionogi & Co., Ltd. Unsponsored ADR OTCMKTS:SGIOY

$8.52 -0.12 (-1.35%)
As of 06/17/2025 03:58 PM Eastern

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

UDG Healthcare stock logo

UDG Healthcare OTCMKTS:UDHCF

$14.79 0.00 (0.00%)
As of 11/29/2021

UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland.

Wilmar International stock logo

Wilmar International OTCMKTS:WLMIY

$23.52 -0.01 (-0.02%)
As of 06/17/2025 03:45 PM Eastern

Wilmar International Limited operates as an agribusiness company in Singapore, South East Asia, the People's Republic of China, India, Europe, Australia/New Zealand, Africa, and internationally. The company operates through four segments: Food Products, Feed and Industrial Products, Plantation and Sugar Milling, and Others. The Food Products segment engages in the processing, branding, and distribution of a range of edible food products, including vegetable oils, sugar, flour, rice, noodles, specialty fats, snacks, bakery, and dairy products, as well as ready-to-eat meals and central kitchen products. The Feed and Industrial Products segment is involved in the processing, merchandising, and distribution of products, such as animal feeds, non-edible palm and lauric products, agricultural commodities, oleochemicals, gas oil, and biodiesel. The Plantation and Sugar Milling segment engages in the cultivation and milling of palm oil and sugarcane. The Others segment provides logistics and jetty port services, as well as engages in investment activities. The company was formerly known as Ezyhealth Asia Pacific Ltd and changed its name to Wilmar International Limited in July 2006. Wilmar International Limited is headquartered in Singapore.